Skip to content

At the Telethon Kids Institute our researchers are searching for answers to improve the health and wellbeing of children and families affected by some of  the most devastating, complex and common diseases and issues.  At any one time we have more than 800 active research projects and 1400 staff and students that include laboratory scientists, clinicians, epidemiologists, bioinformaticians, statisticians, public health professionals and social scientists.

Our research is structured into Research Themes, programs of work and teams.  We are committed to collaboration and work together with other research organisations, clinicians, practitioners, policy makers, consumers and the community to understand the complexity of factors that impact on a child's health and wellbeing and the translation of research findings into action. We actively reward research excellence and offer a range of schemes to support our researchers.

In August 2018, we moved to a purpose-built facility located within Perth Children’s Hospital on the QEII Medical Centre campus - the largest centre of excellence in healthcare, research and education in the southern hemisphere. With a footprint across seven floors, our new home features more than 7000sqm of work space and 2000sqm of laboratories (including specialty suites, equipment rooms and freezer farms), as well as dedicated clinical suites and a cryogenics facility. Our co-location with the Perth Children’s Hospital will enhance our collaboration with clinicians, nursing staff and other allied health professionals, leading to better care, better treatments and better health and development outcomes for our children and young people.

We are an independent medical research institute based in Perth, Western Australia and affiliated with the State's major universities. Our research is  primarily funded through national and international competitive grants and generously supported by donors and governments.

November 2023

Comparison of new computational methods for spatial modelling of malaria

Geostatistical analysis of health data is increasingly used to model spatial variation in malaria prevalence, burden, and other metrics. Traditional inference methods for geostatistical modelling are notoriously computationally intensive, motivating the development of newer, approximate methods for geostatistical analysis or, more broadly, computational modelling of spatial processes.

Published research Geospatial Health and Development Malaria Geospatial Mapping
October 2023

Tertiary prevention and treatment of rheumatic heart disease: a National Heart, Lung, and Blood Institute working group summary

Although entirely preventable, rheumatic heart disease, a disease of poverty and social disadvantage resulting in high morbidity and mortality, remains an ever-present burden in low-income and middle-income countries and rural, remote, marginalised and disenfranchised populations within high-income countries.

Published research Rheumatic Heart Disease Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases
October 2023

Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report

Primary prevention of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) encompasses the timely diagnosis and adequate treatment of the superficial group A Streptococcus (GAS) infections pharyngitis and impetigo. GAS is the only known inciting agent in the pathophysiology of the disease.

Rheumatic Heart Disease Skin Infections Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Healthy Skin and ARF Prevention
December 2023

Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19

Respiratory syncytial virus (RSV) remains a leading cause of mortality and morbidity worldwide. RSV seasonality was disrupted by COVID-19-associated nonpharmaceutical interventions (NPIs). We review RSV seasonality, molecular epidemiology, clinical manifestations, and community awareness to inform future prevention strategies. 

Published research Infectious Diseases Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases COVID-19 Respiratory viral infections

Associate Professor Glenn Pearson

Director of First Nations Strategy and Leadership

BA (Education) PhD Candidate

Professor Ben Jackson

Research Theme Head, Brain and Behaviour

BSc (Hons) PhD

Liz Davis

Head, Chronic & Severe Diseases Research Focus Area; Clinical Lead, Diabetes and Obesity Research


Professor Jane Pillow

Research Theme Head, Early Environment; Team Lead, Chronobiology

BMedSci (Dist) MBBS, PhD (Dist) FRACP